Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene

[1]  E. Bertini,et al.  Characterization of recessive RYR1 mutations in core myopathies. , 2006, Human molecular genetics.

[2]  A. Covacci,et al.  Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia , 2006, Human mutation.

[3]  N. Romero,et al.  Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. , 2006, Brain : a journal of neurology.

[4]  F. Muntoni,et al.  Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes. , 2006, The Biochemical journal.

[5]  I. Nonaka,et al.  0261 Central core disease is due to RyR1 mutations in more than 90% of patients , 2005, Journal of the Neurological Sciences.

[6]  M. Swash,et al.  Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene , 2005, Neurology.

[7]  A. Beggs,et al.  Mutations in dynamin 2 cause dominant centronuclear myopathy , 2005, Nature Genetics.

[8]  S. Ducreux,et al.  Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders , 2005, Neuromuscular Disorders.

[9]  G. Bydder,et al.  Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations , 2004, Neuromuscular Disorders.

[10]  K. Bushby,et al.  111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9–11 November 2002, Naarden, The Netherlands , 2004, Neuromuscular Disorders.

[11]  F. Muntoni,et al.  Effect of Ryanodine Receptor Mutations on Interleukin-6 Release and Intracellular Calcium Homeostasis in Human Myotubes from Malignant Hyperthermia-susceptible Individuals and Patients Affected by Central Core Disease* , 2004, Journal of Biological Chemistry.

[12]  A. Musarò,et al.  118th ENMC International Workshop on Advances in Myotubular Myopathy. 26–28 September 2003, Naarden, The Netherlands. (5th Workshop of the International Consortium on Myotubular Myopathy) , 2004, Neuromuscular Disorders.

[13]  S. Gallati,et al.  X-inactivation patterns in carriers of X-linked myotubular myopathy , 2003, Neuromuscular Disorders.

[14]  P. Mezin,et al.  A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia. , 2003, Human molecular genetics.

[15]  E. Mercuri,et al.  Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation , 2003, Neuromuscular Disorders.

[16]  T. Helliwell,et al.  The spectrum of pathology in central core disease , 2002, Neuromuscular Disorders.

[17]  Susan C. Brown,et al.  Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores , 2002, Neurology.

[18]  A. Lemainque,et al.  A recessive form of central core disease, transiently presenting as multi‐minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene , 2002, Annals of neurology.

[19]  E. Hoffman,et al.  A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy , 2000, Neurology.

[20]  N. Romero,et al.  An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. , 2000, Human molecular genetics.

[21]  E. Mercuri,et al.  Minicore myopathy in children: a clinical and histopathological study of 19 cases , 2000, Neuromuscular Disorders.

[22]  E. Bertini,et al.  Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. , 1997, Human molecular genetics.

[23]  S. Klauck,et al.  A gene mutated in X–linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast , 1996, Nature Genetics.

[24]  A. Clarke,et al.  The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies. , 1995, Journal of medical genetics.

[25]  M. Fardeau,et al.  Myotubular myopathy in a girl with a deletion at Xq27-q28 and unbalanced X inactivation assigns the MTM1 gene to a 600-kb region. , 1995, American journal of human genetics.

[26]  R. Quinn,et al.  Development of malignant hyperthermia during mitral valve replacement. , 1992, The Annals of thoracic surgery.

[27]  S. Tapscott,et al.  Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Fitzsimons,et al.  Myopathy with pathological features of both centronuclear myopathy and multicore disease , 1982, Journal of the Neurological Sciences.

[29]  N. Hülsmann,et al.  Cytopathology of an unusual case of centronuclear myopathy Light- and electron-microscopic investigations , 1981, Journal of the Neurological Sciences.

[30]  Yoke‐Sun Lee,et al.  A fatal congenital myopathy with severe type I fibre atrophy, central nuclei and multicores , 1981, Journal of the Neurological Sciences.

[31]  W. Arts,et al.  Common origin of rods, cores, miniature cores, and focal loss of cross-striations. , 1978, Archives of neurology.

[32]  P. Barth,et al.  X‐linked myotubular myopathy with fatal neonatal asphyxia , 1975, Neurology.

[33]  S. Hamilton,et al.  A Ca2+-binding domain in RyR1 that interacts with the calmodulin binding site and modulates channel activity. , 2006, Biophysical journal.

[34]  V. Dubowitz,et al.  X-linked myotubular myopathy--a long-term follow-up study. , 1998, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[35]  D. Rimoin.  Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics , 1997 .

[36]  Emery.  Diagnostic Criteria for Neuromuscular Disorders , 1997 .